Nanoparticle Carriers for Delivering Paclitaxel in Cancer Treatment
Author Information
Author(s): Liu Yongjin, Zhang Bin, Yan Bing
Primary Institution: School of Chemistry and Chemical Engineering, Shandong University
Hypothesis
Can nanoparticle carriers improve the delivery and effectiveness of paclitaxel in cancer treatment?
Conclusion
Nanoparticle carriers can enhance the solubility and targeting of paclitaxel, improving its therapeutic effects while reducing side effects.
Supporting Evidence
- Nanoparticles can improve the solubility of paclitaxel, which is poorly soluble in water.
- Targeted delivery systems can enhance the effectiveness of paclitaxel while minimizing side effects.
- Different types of nanoparticles, such as polymeric and carbon-based, have shown promise in preclinical studies.
Takeaway
Scientists are using tiny particles to help deliver cancer medicine better, making it work more effectively and with fewer side effects.
Methodology
This review compares various nanoparticle-based delivery systems for paclitaxel in cancer chemotherapy.
Limitations
The safety and long-term effects of these nanoparticles in humans need further evaluation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website